Currently, there are promising approaches in the treatment pipeline including new therapeutic targets, innovations in anti-VEFG dosing and delivery, oral treatments, and gene therapy. With better understanding of the molecular mechanisms and pathophysiology of retinal diseases, alternate pathways are being targeted in various clinical trials. Managed care professionals will benefit from perspectives on novel and investigational therapeutic strategies in the drug pipeline.
- Provider:Medical Education Resources
- Activity Link: https://www.managedcareeye.com/
- Start Date: 2023-12-15 06:00:00
- End Date: 2023-12-15 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.5 hours
Nursing: 0.5 hours
Pharmacy: 0.5 hours - Commercial Support: Source: Regeneron Pharmaceuticals, Inc. - Amount: 3000.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner/Team Competence
- Provider Ship: Jointly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest